Almost two years on from the start of the pandemic here in the UK, Covid-19 patients are today being offered drugs on the NHS to treat the virus. This in itself is a remarkable achievement, when drug development can take considerably longer than this.
Work in medical research never stops, with continuous results and findings. The success in developing a drug to combat Covid-19 will be a result of a collective of existing research and new findings. It is thanks to an army of medical researchers, drug development companies and also vital volunteers taking part in clinical trials over recent months and years.
We have developed effective vaccines and almost 140 million doses have been given here in the UK which means 72.6% of population have had two vaccines and 56% have received a booster *
Everything seems to be pointing to a more normal way of life very soon. Medical developments have had a huge part to play. If anything, this strangest, scariest of times has illustrated to us all just how important volunteers and clinical trials are to help further medicines. Together alongside scientists and researchers, they have allowed us to navigate our way out of the pandemic storm.
I for one, am really proud to be associated in a small way through AWARD Marketing with the amazing medical research and development we have in the UK. By helping leading CROs to attract volunteers and patients to their trials and increasing awareness of what they do, means a lot to me and my team.
Reading this article earlier this month on the BBC has further made me realise just how far we have come in two years and how important medical research is to every single one of us.
*taken from Our World in Data dated 14th February
